Literature DB >> 14977602

Expression of cytochrome P450 in tumor tissues and its association with cancer development.

Tsunehiro Oyama1, Norio Kagawa, Naoki Kunugita, Kyoko Kitagawa, Masanori Ogawa, Tetsunosuke Yamaguchi, Rie Suzuki, Tsuyoshi Kinaga, Yasunori Yashima, Shinichi Ozaki, Toyohi Isse, Yong-Dae Kim, Heon Kim, Toshihiro Kawamoto.   

Abstract

CYPs (cytochrome P450s) catalyze the conversion of numerous numbers of xenobiotics including carcinogens and drugs. CYPs can be involved in metabolic pathways of activation of procarcinogens and/or inactivation of carcinogens during the tumorigenic processes. Recently, increasing number of cancer tissues as well as normal tissues have been found to express a variety of CYPs. The local expression of CYPs in tumors appears to be very important for the management of cancers since CYPs expressed in tumors may be involved in activation and/or inactivation of anticancer drugs. The expression of CYPs in tumors may also convert endogenous substrates to metabolites that facilitate cancer development. In this review, we summarize the association of CYP expression in cancer tissues with carcinogenesis and cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977602     DOI: 10.2741/1378

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  19 in total

1.  Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.

Authors:  Tongmeng Yan; Linlin Lu; Cong Xie; Jiamei Chen; Xiaojuan Peng; Lijun Zhu; Ying Wang; Qiang Li; Jian Shi; Fuyuan Zhou; Ming Hu; Zhongqiu Liu
Journal:  Mol Cancer Ther       Date:  2015-10-29       Impact factor: 6.261

Review 2.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

3.  Antiproliferative effect of the Ginkgo biloba extract is associated with the enhancement of cytochrome P450 1B1 expression in estrogen receptor-negative breast cancer cells.

Authors:  Xiao-Dan Zhao; Ni Dong; Hong-Tao Man; Zhong-Lin Fu; Mei-Hong Zhang; Shuang Kou; Shi-Liang Ma
Journal:  Biomed Rep       Date:  2013-07-22

4.  Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.

Authors:  Ina Bergheim; Christiane Bode; Alexandr Parlesak
Journal:  BMC Gastroenterol       Date:  2005-11-10       Impact factor: 3.067

5.  Correlated fragile site expression allows the identification of candidate fragile genes involved in immunity and associated with carcinogenesis.

Authors:  Angela Re; Davide Cora; Alda Maria Puliti; Michele Caselle; Isabella Sbrana
Journal:  BMC Bioinformatics       Date:  2006-09-18       Impact factor: 3.169

6.  CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Authors:  Elisa M Noll; Christian Eisen; Albrecht Stenzinger; Elisa Espinet; Alexander Muckenhuber; Corinna Klein; Vanessa Vogel; Bernd Klaus; Wiebke Nadler; Christoph Rösli; Christian Lutz; Michael Kulke; Jan Engelhardt; Franziska M Zickgraf; Octavio Espinosa; Matthias Schlesner; Xiaoqi Jiang; Annette Kopp-Schneider; Peter Neuhaus; Marcus Bahra; Bruno V Sinn; Roland Eils; Nathalia A Giese; Thilo Hackert; Oliver Strobel; Jens Werner; Markus W Büchler; Wilko Weichert; Andreas Trumpp; Martin R Sprick
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

7.  LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types.

Authors:  Jung H Kim; Alla Karnovsky; Vasudeva Mahavisno; Terry Weymouth; Manjusha Pande; Dana C Dolinoy; Laura S Rozek; Maureen A Sartor
Journal:  BMC Genomics       Date:  2012-10-04       Impact factor: 3.969

8.  Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.

Authors:  Dora Molina-Ortiz; Rafael Camacho-Carranza; José Francisco González-Zamora; Jaime Shalkow-Kalincovstein; Rocío Cárdenas-Cardós; Rosario Ností-Palacios; Araceli Vences-Mejía
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

9.  Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin.

Authors:  Chhavi Sharma; Andrea J Vas; Payal Goala; Taher M Gheewala; Tahir A Rizvi; Arif Hussain
Journal:  J Oncol       Date:  2014-01-30       Impact factor: 4.375

10.  Targeted CYP2E1 quantification and its correlation to currently acceptable clinical biochemical indices.

Authors:  Anuar Zaini; Iekhsan Othman; Christina Gertrude Yap
Journal:  J Biol Res (Thessalon)       Date:  2016-06-30       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.